EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GNA13 is a new marker for germinal center-derived B cell lymphomas

Xiaokang Ke, Qingping Zhang, Pengcheng Zhu, Huihua He, Jingping Yuan, Qilin Ao

Nano TransMed · 2023

DOI: 10.1016/j.ntm.2023.100002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano TransMed, 2023. Verfasst von Xiaokang Ke und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aim to evaluate the expression of GNA13 in germinal center (GC)-derived B cell lymphomas to evaluate its potential use as marker for diagnosis. Methods and Results: In this study, GNA13 expression was detected by immunohistochemistry in 129 cases of B-cell non-Hodgkin lymphomas (B-NHLs) and 8 cases of angioimmunoblastic T-cell lymphoma (AITL). Furthermore, mutations in the GNA13 gene in 114 cases of B-NHLs were detected by exome sequencing. In 50 cases of diffuse large B-cell lymphoma (DLBCL), 11 cases were positive for GNA13, and all GNA13-positive cases were of the germinal center B-cell-like (GCB) subtype. In 42 cases of follicular lymphoma (FL), the GNA13-positive rate was 100% in FL grade 1, 100% in FL grade 2, 80.0% in FL grade 3 A, and 63.2% in FL grade 3B. In 6 cases of Burkitt lymphoma, 3 cases were positive for GNA13. However, in small lymphocytic lymphoma, mantle cell lymphoma and marginal zone lymphoma, GNA13 was negative or only expressed in the GC. In addition, the GNA13-positive rate was 100% in AITL. The mutation of the GNA13 gene was 27.8% (5/18) in GCB-DLBCL and 10.3% (3/29) in FL, respectively, and mutation of GNA13 occurred in cases with weak positive or negative expression of the GNA13 protein.

Conclusion

GNA13 may be a reliable new marker for GC cells applied in the diagnosis of GC-derived B-cell lymphomas. Its deficiency or low expression may be related to the degree of invasion of GC-derived B-cell lymphomas, and may result from genetic mutations.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ke, X., Zhang, Q., Zhu, P., He, H., Yuan, J., & Ao, Q. (2023). GNA13 is a new marker for germinal center-derived B cell lymphomas. Nano TransMed. https://doi.org/10.1016/j.ntm.2023.100002

Vancouver

Ke X, Zhang Q, Zhu P, He H, Yuan J, Ao Q. GNA13 is a new marker for germinal center-derived B cell lymphomas. Nano TransMed. 2023. doi:10.1016/j.ntm.2023.100002

BibTeX
@article{Ke2023,
  author = {Ke, Xiaokang and Zhang, Qingping and Zhu, Pengcheng and He, Huihua and Yuan, Jingping and Ao, Qilin},
  title = {GNA13 is a new marker for germinal center-derived B cell lymphomas},
  journal = {Nano TransMed},
  year = {2023},
  doi = {10.1016/j.ntm.2023.100002}
}
Kostenlos starten →